Prevalence of Patent Ductus Arteriosus and Treatment Outcome Among Neonates Admitted at Bugando Medical Centre.
Material type:
TextPublisher number: Wurzburg Road 35, Premises, Post Code: 33102 | P. O. Box 1464 Mwanza, Tanzania | Phone: (255) 28-298-3384 | Fax: (255) 28-298-3386 | Email: vc@bugando.ac.tz | Website: www.bugando.ac.tz. Language: English Language: Kiswahili Publication details: Mwanza, Tanzania | Catholic University of Health and Allied Sciences [CUHAS-Bugando] | 2024.Description: 42 Pages; Includes ReferencesSubject(s): Summary: Abstract:
Introduction: Patent Ductus Arteriosus (PDA) is one of the most common congenital heart diseases (CHDs) in infants accounting 5% to 10% of all CHDs, associated with high rate of morbidity and mortality. Despite a wide range of pharmacological management (widely used Indomethacin, ibuprofen and acetaminophen) and surgical interventions which may benefits several infants, there is increasing treatment controversy varying markedly between institutions and health care providers. Therefore, this study aimed at determining the prevalence of PDA and outcome of neonates treated with Acetaminophen in Mwanza, Tanzania
Methodology: A hospital based retrospective study reviewing neonatal data from January to August 2024 in Bugando Medical Centre (BMC) was conducted. A total of 304 neonatal records were extracted in the study by random sampling. Data collection and entry was done using Eppicollect5 application where demographic information and relevant clinical data like, mode of delivery, vitals, reason for admission, ECHO findings before and after treatment, duration of hospital stay and outcome were obtained from patient’s file. SPSS Software version 20 was used for data analysis.
Results: A total of 304 neonates’ records were analysed. The Median age of enrolled neonates was 1(IQR:1-22) and more than half,169(55.6%) were male. The prevalence of PDA among all neonates admitted was 18(5.9%). The prevalence of PDA among neonates with congenital heart diseases was 18(64.3%). The treatment outcome of neonates with PDA after seven days on acetaminophen, ECHO report revealed 12(66.7%) neonates attained full closure, and 2(11.1%) had small PDA. 3(16.7%) died before evaluation ECHO. However, by using Chi squared test no predictors for PDA closure were found in this study.
Conclusion: PDA is the most common congenital heart defect in our setting, with good response to acetaminophen treatment. This request for prompt evaluation and intervention to all neonates at risk. However, in this study there was no predictors for early PDA closure.
| Item type | Current library | Status | Barcode | |
|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | Not for loan | 20240913110944.0 |
Abstract:
Introduction: Patent Ductus Arteriosus (PDA) is one of the most common congenital heart diseases (CHDs) in infants accounting 5% to 10% of all CHDs, associated with high rate of morbidity and mortality. Despite a wide range of pharmacological management (widely used Indomethacin, ibuprofen and acetaminophen) and surgical interventions which may benefits several infants, there is increasing treatment controversy varying markedly between institutions and health care providers. Therefore, this study aimed at determining the prevalence of PDA and outcome of neonates treated with Acetaminophen in Mwanza, Tanzania
Methodology: A hospital based retrospective study reviewing neonatal data from January to August 2024 in Bugando Medical Centre (BMC) was conducted. A total of 304 neonatal records were extracted in the study by random sampling. Data collection and entry was done using Eppicollect5 application where demographic information and relevant clinical data like, mode of delivery, vitals, reason for admission, ECHO findings before and after treatment, duration of hospital stay and outcome were obtained from patient’s file. SPSS Software version 20 was used for data analysis.
Results: A total of 304 neonates’ records were analysed. The Median age of enrolled neonates was 1(IQR:1-22) and more than half,169(55.6%) were male. The prevalence of PDA among all neonates admitted was 18(5.9%). The prevalence of PDA among neonates with congenital heart diseases was 18(64.3%). The treatment outcome of neonates with PDA after seven days on acetaminophen, ECHO report revealed 12(66.7%) neonates attained full closure, and 2(11.1%) had small PDA. 3(16.7%) died before evaluation ECHO. However, by using Chi squared test no predictors for PDA closure were found in this study.
Conclusion: PDA is the most common congenital heart defect in our setting, with good response to acetaminophen treatment. This request for prompt evaluation and intervention to all neonates at risk. However, in this study there was no predictors for early PDA closure.
There are no comments on this title.
Click on an image to view it in the image viewer